Celia M Alpuche-Aranda

Dr. Celia M Alpuche-Aranda

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2022 in Veterinary World
Verified
Journal Article
Open access
MVMaria Elena Velazquez-Meza
Maria Elena Velazquez-Meza
MGMiguel Galarde-López
Miguel Galarde-López
BCBerta Alicia Carrillo-Quiroz
Berta Alicia Carrillo-Quiroz
CACelia M Alpuche-Aranda
Celia M Alpuche-Aranda
In this research, a review of antimicrobial resistance (AMR) is conducted as part of the One Health approach. A review of publications, which included "antimicrobial resistance" and "One Health," was conducted. Among the global health problems, AMR is the one that most clearly illustrates the One Health approach. AMR is a critical global problem affecting humans, the environment, and animals. This is related to each of these three components due to the irresponsible and excessive use of antimicrobials in various sectors (agriculture, livestock, and human medicine). Improper management of antimicrobials, inadequate control of infections, agricultural debris, pollutants in the environment, and migration of people and animals infected with resistant bacteria facilitate the spread of resistance. The study aimed to analyze the problem of AMR from a health perspective to analyze the different actors involved in One Health.

3 May 2021 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
MMMartin romero martinez
Martin romero martinez
TBTonatiuh Barrientos-Gutiérrez
Tonatiuh Barrientos-Gutiérrez
LCLucia Cuevas-Nasu
Lucia Cuevas-Nasu
SBSergio Bautista-Arredondo
Sergio Bautista-Arredondo
MCM. Arantxa Colchero
M. Arantxa Colchero
TLTeresa Shamah Levy
Teresa Shamah Levy
Objetivo. Describir el diseño y los resultados de campo de la Encuesta Nacional de Salud y Nutrición (Ensanut) 2020 so­bre Covid-19. Material y métodos. La Ensanut Covid-19 es una encuesta probabilística de hogares. En este artículo se describen los siguientes elementos del diseño: alcance, muestreo, medición, inferencia y logística. Resultados. Se obtuvieron 10 216 entrevistas de hogar completas y 9 464 resultados sobre seropositividad a SARS-CoV-2. La tasa de respuesta de hogar fue 80% y la de prueba de seropositividad de 44%. Conclusiones. El diseño probabilístico de la Ensa­nut Covid-19 permite hacer inferencias estadísticas válidas sobre parámetros de interés para la salud pública a nivel nacional y regional; en particular, permitirá hacer inferencias de utilidad práctica sobre la prevalencia de seropositividad a SARS-CoV-2 en México. Además, la Ensanut Covid-19 podrá ser comparada con Ensanut previas para identificar potenciales cambios en los estados de salud y nutrición de la población mexicana.

26 August 2022 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
MMMartin romero martinez
Martin romero martinez
TBTonatiuh Barrientos-Gutiérrez
Tonatiuh Barrientos-Gutiérrez
LCLucia Cuevas-Nasu
Lucia Cuevas-Nasu
SBSergio Bautista-Arrendondo
Sergio Bautista-Arrendondo
MCM. Arantxa Colchero
M. Arantxa Colchero
TLTeresa Shamah Levy
Teresa Shamah Levy
Objetivo. Presentar el diseño de la Encuesta Nacional de Salud y Nutrición (Ensanut) 2022 y cuantificar el avance de la Ensanut Continua 2020-2024. Material y métodos. La Ensanut 2022 es la tercera encuesta de la serie de en­cuestas denominada Ensanut Continua 2020-2024. En este documento se describe el alcance de la Ensanut 2022 y sus procedimientos de muestreo, medición y organización logís­tica. Además, se presenta el avance esperado de la Ensanut Continua 2020-2024 al concluir la Ensanut 2022. Resulta­dos. La Ensanut 2022 obtendrá, a nivel nacional, al menos 10 160 entrevistas completas de hogar y 9 441 resultados de seropositividad a SARS-CoV-2. Conclusiones. La Ensanut 2022 estimará la prevalencia de seropositividad a SARS-CoV-2 a nivel nacional y regional y avanzará en la acumulación de información para alcanzar los objetivos de la Ensanut Con­tinua 2020-2024.

5 November 2021 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
MMMartin romero martinez
Martin romero martinez
TBTonatiuh Barrientos-Gutiérrez
Tonatiuh Barrientos-Gutiérrez
LCLucia Cuevas-Nasu
Lucia Cuevas-Nasu
SBSergio Bautista-Arredondo
Sergio Bautista-Arredondo
MCM. Arantxa Colchero
M. Arantxa Colchero
TLTeresa Shamah Levy
Teresa Shamah Levy
Objetivo. Describir el diseño de la Encuesta Nacional de Salud y Nutrición 2021 (Ensanut 2021). Material y métodos. La Ensanut 2021 es una encuesta probabilística de hogares que forma parte de la serie de Ensanut Continua 2020-2024. En esta ocasión se describen el alcance, el muestreo, la medición y la organización logística. Resultados. Se planea obtener al menos 12 060 entrevistas de hogar completas a nivel nacional y 9 837 muestras para determinar seropositividad a SARS-CoV-2 a nivel nacional. Conclusiones. La Ensanut 2021 permitirá realizar inferencias regionales sobre la prevalencia de seropositividad a SARS-CoV-2 y también acumular información para realizar inferencias estatales en el año 2024.

17 March 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
CGCarlos Gaspar-Castillo
Carlos Gaspar-Castillo
MRMario H. Rodríguez
Mario H. Rodríguez
VOVianney Ortiz-Navarrete
Vianney Ortiz-Navarrete
CACelia M Alpuche-Aranda
Celia M Alpuche-Aranda
JMJesus Martinez-Barnetche
Jesus Martinez-Barnetche
Dengue and Zika are arthropod-borne viral diseases present in more than 100 countries around the world. In the past decade, Zika emerged causing widespread outbreaks in new regions, where dengue has been endemic-epidemic for a long period. The wide and extensive dissemination of the mosquito vectors, Aedes aegypti, and Ae. albopictus, favor the co-existence of both infections in the same regions. Together with an important proportion of asymptomatic infections, similar clinical manifestations, and a short time window for acute infection confirmatory tests, it is difficult to differentially estimate both dengue and Zika incidence and prevalence. DENV and ZIKV flavivirus share high structural similarity, inducing a cross-reactive immune response that leads to false positives in serological tests particularly in secondary infections. This results in overestimation of recent Zika outbreaks seroprevalence in dengue endemic regions. In this review, we address the biological basis underlying DENV and ZIKV structural homology; the structural and cellular basis of immunological cross reactivity; and the resulting difficulties in measuring dengue and Zika seroprevalence. Finally, we offer a perspective about the need for more research to improve serological tests performance.

3 September 2021 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
MCMartha Carnalla
Martha Carnalla
ABAna Basto-Abreu
Ana Basto-Abreu
DSDalia Stern
Dalia Stern
SBSergio Bautista-Arredondo
Sergio Bautista-Arredondo
TLTeresa Shamah Levy
Teresa Shamah Levy
TBTonatiuh Barrientos-Gutiérrez
Tonatiuh Barrientos-Gutiérrez
Objective. To estimate the willingness to vaccinate against Covid-19 (acceptance) in the Mexican population and to iden­tify socioeconomic factors associated with vaccine hesitancy and refusal. Materials and methods. We estimated the acceptance, refusal and hesitancy proportions using data from the Covid-19 National Health and Nutrition Survey conducted from August to November 2020. Factors associated with re­fusal and hesitancy were explored using multinomial logistic regression. Results. Covid-19 vaccination acceptance was 62.3%, refusal 28.2% and hesitancy 9.5%. Refusal and hesitancy were associated with being female, having older age, lower educational level, lower socioeconomic status and working in the informal sector. Conclusion. National campaigns to incentivize vaccine acceptance need to consider specific subgroups were the likelihood of hesitancy and refusal is high. In Mexico, refusal and hesitancy were higher in vulnerable groups, and people at a higher risk of Covid-19 complica­tions and death.